生物活性 靶点 体外研究 体内研究
ChemicalBook  CAS数据库列表  化合物 T11896

化合物 T11896

化合物 T11896,2449093-46-1,结构式
化合物 T11896
  • CAS号:2449093-46-1
  • 英文名:Propanoic acid, 3-[[[4-[2-(7-chloro-4-quinolinyl)ethenyl]phenyl][(2-phenylethyl)thio]methyl]thio]-
  • 中文名:化合物 T11896
  • CBNumber:CB88250483
  • 分子式:C29H26ClNO2S2
  • 分子量:520.11
  • MOL File:2449093-46-1.mol
化合物 T11896化学性质
  • 沸点 :718.4±60.0 °C(Predicted)
  • 密度 :1.317±0.06 g/cm3(Predicted)
  • 储存条件 :Store at -20°C
  • 溶解度 :DMSO : 135 mg/mL (259.56 mM; Need ultrasonic)
  • 酸度系数(pKa) :4.28±0.10(Predicted)
  • 形态 :Solid
  • 颜色 :Light yellow to yellow

化合物 T11896性质、用途与生产工艺

  • 生物活性 LV-320 是一种有效且非竞争性的 ATG4B 抑制剂,其 IC50 值为 24.5 μM,Kd 值为 16 μM。 LV-320 抑制 ATG4B 的酶促活性,阻断细胞自噬,并且在体内稳定,无毒且有活性。
  • 靶点

    IC50: 24.5 µM (ATG4B); Kd: 16 μM (ATG4B)

  • 体外研究

    LV-320 (0-120 µM; SKBR3, MCF7, JIMT1, and MDA-MB-231 cells) treatment results in a dose-dependent increase in endogenous LC3B-II and protein p62 levels in all four cell lines.
    LV-320 (120 µM; 48 hours; MDA-MB-231 cells) treatment results in an increase in LC3B-II, indicating that LV-320 blocks autophagic flux.

    Western Blot Analysis

    Cell Line: SKBR3, MCF7, JIMT1, and MDA-MB-231 cells
    Concentration: 0 µM, 25 µM, 50 µM, 75 µM, 100 µM, or 120 µM
    Incubation Time:
    Result: Resulted in a dose-dependent increase in endogenous LC3B-II and protein p62 levels in all four cell lines.

    Cell Autophagy Assay

    Cell Line: MDA-MB-231 cells
    Concentration: 120 µM
    Incubation Time: 48 hours
    Result: Blocked autophagic flux.
  • 体内研究

    LV-320 (100-200 mg/kg; oral gavage; three times over two days; GFP-LC3 mice) treatment results in a terminal blood level of 169 µM and a liver level of 104 µM. The expression of GFP-LC3 puncta is significantly greater accumulation in LV-320 treated animals compared to controls. LC3B-II protein is also increased in LV-320-treated animals. The treatment do not cause significant toxicity in mice at either dose.

    Animal Model: GFP-LC3 mice (females, 9-14 weeks)
    Dosage: 100 mg/kg or 200 mg/kg
    Administration: Oral gavage; three times over two days (Pharmacokinetic study)
    Result: Terminal blood levels were 169 µM and liver levels were 104 µM. LC3B-II protein level was also increased.
化合物 T11896上下游产品信息
上游原料
下游产品
化合物 T11896生产厂家
  • 公司名称:TargetMol中国(陶术生物)
  • 联系电话: 4008200310
  • 电子邮件:marketing@tsbiochem.com
  • 国家:中国
  • 产品数:24017
  • 优势度:58
  • 公司名称:銳迪國際科技有限公司
  • 联系电话: 18024082417
  • 电子邮件:market@ubiochem.com
  • 国家:中国
  • 产品数:9154
  • 优势度:58
  • 公司名称:Aladdin Scientific
  • 联系电话:+1-+1(833)-552-7181
  • 电子邮件:sales@aladdinsci.com
  • 国家:美国
  • 产品数:52927
  • 优势度:58